Key facts
- Happydemics’s last known valuation is $74.2M.
- It has raised $27.2M; the latest was Later Stage VC ($13.8M) in Dec 2024.
- Notable investors include Bpifrance, Kima Ventures, Techmind, Wille Finance, Adelie Capital — 22 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 22 names
- ·Watchlist + deal alerts for Happydemics
- ·The full record, as it builds
Funding rounds
No funding rounds for Happydemics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Happydemics
Developer of a marketing and advertising performance platform intended to support brands in understanding their consumer reactions to the content or product. The company's platform provides an audience analysis tool that helps in optimizing advertising speech and facilitates mobile activity analysis, its standardized methodology with access to benchmarks, and its trusted third-party position make it the market-approved partner to compete in increasingly saturated markets, which measures the performance of media investments, enabling clients to optimize their advertising campaigns and adapt their commercial offerings.
- Sector
- Information Technology
- HQ
- Paris, France
- Founded
- 2015
- Employees
- 68
- Website
- happydemics.com/
- Ownership
- Privately Held (backing)
Happydemics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Happydemics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Happydemics in its N-PORT filings yet. We sweep new filings monthly.